In the face of rising antibiotic resistance, the development of a new class of antibiotics is a beacon of hope for combating drug-resistant infections.Kinvard Bio, a pioneering biotechnology startup, is at the forefront of this revolutionary effort, creating innovative compounds that demonstrate promise against some of the most challenging diseases caused by drug-resistant bacteria.